Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic effects of olanzapine vs ziprasidone in schizophrenia
NCT00148564Phase 4Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Mar 2004
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of olanzapine, ziprasidone in schizophrenia, sponsored by Charité – Universitätsmedizin Berlin. Started Mar 2004; status: completed.
02
Drugs
olanzapineziprasidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00148564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00148564.